Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1549-490x|23|1|2-e5

ISSN: 1083-7159

Source: The Oncologist, Vol.23, Iss.1, 2018-01, pp. : 2-e5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content